Verimatrix Virtual Summit to Offer the Industry’s Latest Insights into Secure Video Delivery and Mobile Application Protection July 8-9
Verimatrix, (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced its second virtual event this year designed to showcase how the global expansion of video, applications and connected devices has multiplied today’s attack surfaces. The Verimatrix Summer Summit consists of webcasts and private meetings taking place Wednesday, July 8, and Thursday, July 9, 2020.
“Now more than ever, organizations need to provide their customers with compelling experiences – but those experiences must be protected,” said Asaf Ashkenazi, COO of Verimatrix. “The Verimatrix Summer Summit will showcase why security matters more than ever -- and why in today’s modern connected world, security should be intuitive, user-friendly, and fast."
To kick off the Summit, Verimatrix Chairman and CEO Amedeo D’Angelo will underscore the importance of reliable and trustworthy security in the high-growth areas of video content, mobile applications and connected devices.
Verimatrix Virtual Summit Experience
Trusted Security: What it Means to Be a Trusted Security Partner
Wednesday, July 8, 6:30am PT / 1:30pm GMT
Amedeo D’Angelo, Chairman and CEO of Verimatrix, will explore what it means to be a trusted security partner, how the global expansion of video, applications and connected devices has multiplied today’s attack surfaces, and why the future of scalable, cost-effective SaaS security in the cloud is so exciting.
Every Second Counts: Building Better Sports Fan Experiences Through Secure Mobile Apps and Connected Game Play
Wednesday, July 8, 7:00am PT / 2:00pm GMT
Produced and moderated by SportsPro, this webinar will showcase how today’s technological change is forever altering fan perceptions and demands for the sporting experience. Franchises who provide trusted gameday ecosystems will win over the hearts, minds and pocketbooks of fans – while preserving valuable revenue streams. Panelists include Leanne Johnson, VP of Digital for the Milwaukee Bucks and Lucas von Cranach, CEO and Founder of Onefootball. Eoin Connolly, Editor-At-Large for SportsPro, will moderate.
Cloud Speed Ahead: Unlocking New Opportunities with Secure Content Distribution
Wednesday, July 8, 8:00am PT / 3:00pm GMT
Produced by Omdia, this webinar will explore how content providers are efficiently setting up new distribution channels around the world by maximizing novel OTT direct-to-consumer strategies without breaking the bank. Allen Tatara, Sr. Manager, Webinar Events at Omdia will moderate. Panelists will include Geoff Stedman, Enterprise Media Strategist at AWS Elemental, Asaf Askenazi, Chief Operating Officer at Verimatrix and Merrick Kingston, Associate Director at Omdia.
Apps Under Siege: Understanding Today’s Threats to Web/Mobile Applications and How to Defend Your IP While Safeguarding Customers
Wednesday, July 8, 11:30am PT / 6:30pm GMT
Experts from Jscrambler and Verimatrix will discuss how the lack of application protection is a giant blind spot and source of risk for many companies. Whether they want to acknowledge it or not, virtually every company today is in the app business. This webinar will reveal how to protect apps from harm without degrading the user experience. Lu Bolden, Chief Revenue Officer at Verimatrix will moderate. Panelist will include Pedro Fortuna, Co-Founder & CTO at Jscrambler and Neal Michie, Director Product Management at Verimatrix.
Defend and Protect: How Cybercriminals Are Hacking Healthcare Workflows & How to Stop Them
Thursday, July 9, 8:00am PT / 3:00pm GMT
Moderated by Adam Turinas, this panel session will explore how cybercriminals can cripple healthcare workflows. It will uncover how tele-health platforms, apps and devices can be hacked relatively easily, share examples of breaches and review the latest security techniques. The results of a security effectiveness test of the world’s top 20 healthcare apps will be shared during the session. The webinar will be moderated by Adam Turinas, CEO & Founder of HealthLaunchpad. Panelists include John Ulett, CIO of CentraState Healthcare System, John Hendricks, CTO of Huntzinger Management Group, Brian Lawrence, Director Solution Engineering at NowSecure and Asaf Ashkenazi, Chief Operating Officer at Verimatrix.
Churning It Around: How to Identify and Retain At-Risk Video and Internet Service Subscribers Using Data Stories
Thursday, July 9, 9:00am PT / 4:00pm GMT
This panel will explore how security vendors and systems integrators are working with operators to utilize the latest data harvesting & analytics tools to surface subscriber profitability stories. This can lead to actionable insights powerful enough to boost consumption rates, reduce churn and increase ARPU – all of which are especially critical in a climate of tight pocketbooks caused by COVID-19. Moderated by Sebastian Braun, Director Product Management at Verimatrix, this panel will feature Luc Bleylevens, Senior Product Director, Subscriber Retention Management at Cleeng, Daragh O Brien, CEO & Managing Director of Castlebridge and Derek Harrar, CEO of Zodiac.
Adapt or Die: The Content Distribution Business Model in Flux
Thursday, July 9, 11:30am PT / 6:30pm GMT
Speakers from Xperi (TiVo) and 3Vision come together for this insightful session on the impact of COVID-19 on the traditional Hollywood business and their audiences. Topics to be explored include what’s changing within the content distribution business model and why, the shifting power of content producers, trends in security technologies and integration methods and more. Moderated by Lu Bolden, Chief Revenue Officer at Verimatrix, this webinar will feature Nic Wilson, Head of Customer Success at TiVo and Jack Davison, EVP of 3Vision.
To learn more about the Verimatrix Summer Summit, or register to attend any of the sessions go to www.summit.verimatrix.com.
Verimatrix (Euronext Paris: VMX) helps power the modern connected world with security made for people. We protect digital content, applications, and devices with intuitive, people-centered and frictionless security. Leading brands turn to Verimatrix to secure everything from premium movies and live streaming sports, to sensitive financial and healthcare data, to mission-critical mobile applications. We enable the trusted connections our customers depend on to deliver compelling content and experiences to millions of consumers around the world. Verimatrix helps partners get to market faster, scale easily, protect valuable revenue streams, and win new business. To learn more, visit www.verimatrix.com.
Investor and media
Richard Vacher Detournière
General Manager & Chief Financial Officer
+33 (0)4 42 905 905
+1 619 224 1261
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Sigfox and Cube Infrastructure Managers Announce Major Partnership in IoT Infrastructure18.9.2020 09:30:00 CEST | Press release
Sigfox, the global 0G network1 and cloud provider for industrial data, is proud to announce a new strategic alliance with Cube Infrastructure Managers (Cube), through the sale of its German 0G network to Cube. Sigfox has grown its 0G IoT services by rolling out 0G networks across 72 countries and regions, which was largely achieved with partners called Sigfox Operators. These operators are the owners of the 0G networks, which they operate as exclusive connectivity providers of Sigfox IoT services, offering worldwide connectivity to customers. The sale of the German network to Cube will allow Sigfox to finance its continued innovation efforts in data value extraction and improvements in cloud algorithms to reduce energy consumption and allow the implementation of even more cost-effective devices and sensors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200918005116/en/ Cube Infrastructure Managers, the European infrastructu
Sensorion successfully raises approximately €31 (US$ 36.5) million in an oversubscribed private placement to US and European investors18.9.2020 08:00:00 CEST | Press release
Regulatory News: Not for release, publication or distribution, directly or indirectly, in or into the United States, Canada, Australia or Japan. This press release is not intended as an offer and is for informational purpose only Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN – the “Company”) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders announces today the success of its previously announced capital increase. The Company has placed 18,236,000 new ordinary shares with a nominal value of €0.10 each (the “New Shares”), for total gross proceeds of approximately € 31 million by means of an accelerated bookbuild offering to the benefit of categories of persons (the “Reserved Offering”). The issue price of the New Shares is €1.70 per share, representing a 3.5% discount to the weighted average share price on the day preceding the date on which the issuance price
ESMO 2020: Phase II CLARINET FORTE Results Show Increasing Dose Frequencies of Somatuline ® Autogel ® (lanreotide) Allows Patients with NETs to Delay Treatment Escalation by up to 8.3 Months18.9.2020 07:00:00 CEST | Press release
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced the release of first efficacy and safety data from the CLARINET FORTE study, with the abstract to be presented as a mini-oral presentation at the 2020 European Society for Medical Oncology (ESMO) Congress, taking place virtually from 19-21 September 2020. The prospective single-arm, open-label, exploratory, international Phase II study investigated the efficacy and safety of increasing the dose frequency of Somatuline® Autogel®(lanreotide) in patients with pancreatic or midgut NETs with centrally-assessed progression within the last two years while on a standard lanreotide regimen for ≥24 weeks. An extension of progression-free survival (PFS) rates and encouraging disease-control rates (DCR) were recorded in both tumor types, with no new safety signals. “These results support a clinically meaningful benefit to a population of patients with high unmet medical need by potentially delaying escalation to more toxic treatmen
Vifor Pharma Group Announces Successful Sale of OM Pharma18.9.2020 07:00:00 CEST | Press release
Regulatory News: Vifor Pharma has today announced the successful sale of 100% of the share capital of OM Pharma, a Vifor Pharma Group company to Optimus Holding Ltd. The terms of the deal include: A purchase consideration of MCHF 435 for 100% of the share capital An earn out related to potential future value gains on 20% of Optimus Holding Ltd. equity to be determined before the end of 2027 upon a trade sale, IPO or EBITDA multiple This earn out together with the purchase consideration could result in a total transaction value exceeding MCHF 500. The deal is expected to close within 30 days. OM Pharma is a Geneva-based company mainly active in the field of microbial derived immunotherapeutics and has developed strongly outside the core strategy of Vifor Pharma over the past few years. Optimus Holding Ltd. is a Swiss Group, founded by Etienne Jornod together with long-standing Swiss entrepreneurs and Abdi Ibrahim (28.5%), a Turkey-based pharmaceutical company operating in 12 countries a
A Continuous Journey of Digital Transformation, Alibaba Cloud and Its Global Customers at Apsara 202018.9.2020 05:00:00 CEST | Press release
As the digital technology and intelligence backbone of Alibaba Group, Alibaba Cloud is experiencing continuous growth alongside its customers across different parts of the world. Over the years, it has made relentless efforts to serve clients from every industry, helping them accelerate their business development and navigate the challenges of these volatile times. Cloud computing and AI technology have been shown to be the cornerstone for businesses seeking to be fully equipped in the digital era, especially following the global outbreak of COVID-19. At the 12th Apsara Conference: Leap into the Future of Digital Intelligence, customers from various sectors, including aviation, leisure and hospitality, education, and e-commerce and retail, share their growth and success stories achieved together with Alibaba Cloud. “It is our utmost pleasure to see our customers experience a seamless transition into more digitalised operations,” said Selina Yuan, President for International Business, A
BeiGene Presents Data at ESMO Virtual Congress 2020 on Phase 3 Trial of Tislelizumab in First-Line Non-Squamous Non-Small Cell Lung Cancer and Phase 2 Trial of Pamiparib in Advanced Ovarian Cancer18.9.2020 00:05:00 CEST | Press release
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced the first reported data from RATIONALE 304, the Phase 3 trial of its anti-PD-1 antibody tislelizumab in combination with chemotherapy as a potential first-line treatment for patients with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC), and the first reported data from the pivotal Phase 2 trial of its investigational PARP inhibitor pamiparib in advanced ovarian cancer (OC) at the European Society for Medical Oncology (ESMO) Virtual Congress 2020, which takes place on September 19-21. “We are pleased to share the promising RATIONALE 304 results, which were used to support our recently accepted supplemental new drug application in first-line non-squamous NSCLC in China,” commented Yong (Ben) Ben, M.D., Chief Medical Officer, Immuno-Oncology at BeiGene. “BeiGene is evaluating tislelizuma